60 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Entera Bio Ltd. ENTX shares jumped 284% to $6.15 after the company disclosed positive topline EB613 Phase 2 biomarker data.
• Nova LifeStyle, Inc. NVFY shares surged 112.1% to $5.09.
• PDS Biotechnology Corporation PDSB jumped 64.6% to $6.24 after the company announced its COVID-19 vaccine consortium received a commitment from the MCTI to fund clinical development and commercialization of a Versamune-based COVID-19 vaccine with an award of up to $60 million.
• Timber Pharmaceuticals, Inc. TMBR gained 37.1% to $2.77.
• Vir Biotechnology, Inc. VIR rose 32.2% to $61.92. Vir Biotechnology and GSK disclosed that VIR-7831 reduced hospitalization and risk of death in early treatment of adults with COVID-19.
• Takung Art Co., Ltd. TKAT jumped 31.8% to $3.599.
• RYB Education, Inc. RYB surged 30.3% to 4.56.
• Longeveron Inc. LGVN gained 30% to $9.34 after the company’s Lomecel-B was approved by the FDA for compassionate use for the treatment of child with hypoplastic left heart syndrome.
• Lizhi Inc. LIZI jumped 25.3% to $9.90. Lizhi on Tuesday reported better-than-expected Q4 EPS and sales results.
• Siebert Financial Corp. SIEB gained 25.2% to $5.39 following FY20 results. The company reported FY20 sales of $54.9 million, up from $28.6 million year over year.
• Contrafect Corporation CFRX surged 25.2% to $6.36.
• Super League Gaming, Inc. SLGG shares rose 25% to $6.93 after the company announced the acquisition of Mobcrush.
• OrganiGram Holdings Inc. OGI gained 24.6% to $3.6012 after the company announced it formed a product development collaboration with BAT, which includes a strategic investment from BAT for 19.9% equity interest.
• Spark Networks SE LOV surged 24.5% to $6.10.
• RLX Technology Inc. RLX jumped 23.8% to $19.02.
• Innodata Inc. INOD gained 23.3% to $7.34 following Q4 results.
• FinVolution Group FINV rose 22.2% to $6.19 after the company reported Q4 results.
• Inspired Entertainment, Inc. INSE gained 22.1% to $9.44 after the company reported better-than-expected Q4 EPS and sales results.
• UP Fintech Holding Limited TIGR surged 21.5% to $23.36.
• Torchlight Energy Resources, Inc. TRCH gained 21.4% to $2.745.
• IMAC Holdings, Inc. IMAC shares jumped 21% to $2.54.
• Alimera Sciences, Inc. ALIM gained 20.8% to $11.20.
• CooTek (Cayman) Inc. CTK surged 20.2% to $3.1365.
• Qutoutiao Inc. QTT gained 18.2% to $2.9080.
• Beam Global BEEM shares jumped 17.9% to $45.56.
• Bumble Inc. BMBL surged 17.6% to $73.97 following Q4 results.
• 22nd Century Group, Inc. XXII gained 16.6% to $2.59 following Q4 results.
• Everspin Technologies, Inc. MRAM surged 16.6% to $6.04.
• China HGS Real Estate Inc. HGSH rose 16.1% to $2.09.
• GeoVax Labs, Inc. GOVX rose 16% to $5.58. GeoVax, last week, announced filing of two additional COVID-related patent applications.
• Altimmune, Inc. ALT gained 15.8% to $17.03.
• Rush Street Interactive, Inc. RSI rose 13.7% to $18.81 following Q4 results.
• Catabasis Pharmaceuticals, Inc. CATB gained 10.3% to $3.3312 after Oppenheimer upgraded the stock from Perform to Outperform and announced a price target of $5 per share.
• SCWorx Corp. WORX shares rose 9% to $1.9190.
• ReneSola Ltd SOL rose 8.7% to $14.99. Raymond James recently initiated coverage on the stock with an Outperform rating and announced a $14.5 price target.
• Emerson Radio Corp. MSN rose 7.3% to $1.4048.
• Asana, Inc. ASAN rose 6% to $33.80 after the company reported better-than-expected Q4 results and issued strong Q1 sales guidance.

Check out these big penny stock gainers and losers

Losers

• Just Energy Group Inc. JE fell 23.5% to $1.99. The company announced that the Toronto Stock Exchange and the New York Stock Exchange have commenced delisting proceedings.
• Celsius Holdings, Inc. CELH shares dipped 20.2% to $48.30 after the company reported Q4 results
• Enveric Biosciences, Inc. ENVB fell 19% to $3.68. Enveric Biosciences shares jumped 55% on Wednesday in reaction to acquiring an exclusive, perpetual license for novel molecules from Diverse Biotech.
• MediciNova, Inc. MNOV fell 19.1% to $7.07. MediciNova shares gained around 54% on Wednesday after the biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to repurpose MN-166 (ibudilast) as a potential medical countermeasure against lung damage induced by chlorine gas.
• AVEO Pharmaceuticals, Inc. AVEO shares fell 19.6% to $12.29. The FDA has finally approved AVEO Pharmaceuticals’ tivozanib for advanced renal cell carcinoma, nine years after it first submitted its marketing application to the agency.
• Cemtrex, Inc. CETX fell 18.4% to $2.09. Cemtrex shares jumped 53% on Wednesday with abnormally high session volume.
• Invacare Corporation IVC dropped 18.1% to $8.16.
• Alto Ingredients, Inc. ALTO fell 18% to $5.97 following Q4 results. The company posted a Q4 loss of $0.30 per share.
• Fossil Group, Inc. FOSL tumbled 17.1% to $14.97 after the company reported Q4 results and named Sunil Doshi as CFO.
• Koss Corporation KOSS fell 17% to $25.15 after surging around 69% on Wednesday.
• Amplify Energy Corp. AMPY dropped 16.7% to $3.33 after the company reported worse-than-expected Q4 sales.
• New Concept Energy, Inc. GBR fell 15.7% to $5.57 after gaining 45% on Wednesday.
• INVO Bioscience, Inc. INVO fell 14.9% to $5.49 after dropping around 32% on Wednesday. The company’s stock jumped 202% on Tuesday after the company said it has amended its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals.
• Verb Technology Company, Inc. VERB dropped 14.8% to $1.72 after the company announced a 9.375 million share common stock offering and priced it at $1.60 per share.
• NV5 Global, Inc. NVEE dropped 14.5% to $91.56 after the company priced its underwritten public offering of common stock.
• Cloudera, Inc. CLDR fell 13.2% to $12.78. Cloudera reported upbeat quarterly results, but issued weak FY22 guidance.
• Sumo Logic, Inc. SUMO fell 13% to $22.41 after the company reported Q4 earnings results and issued Q1 & FY21 guidance. The company also announced it signed a definitive agreement to acquire DFLabs.
• Exela Technologies, Inc. XELA fell 12.2% to $3.66 after declining 10% on Wednesday. Exela Technologies recently won a 10-year, $90-million contract delivering data transformation solutions for a major US insurer.
• Red Violet, Inc. RDVT dropped 11.7% to $18.89. Red Violet, on Wednesday, released Q4 results.
• Kadmon Holdings, Inc. KDMN shares fell 10.7% to $4.39 after the company announced the FDA extended the review period for the New Drug Application for belumosudil for the treatment of chronic graft-versus-host disease.
• Savara Inc.SVRA fell 10.3% to $1.6050 after reporting a common stock offering. The company in an 8-K reported it entered a Master Services Agreement with Parexel to provide contract services related to clinical trials conducted by the company.
• Clearside Biomedical, Inc. CLSD fell 7.7% to $3.25 after the company reported worse-than-expected Q4 results.
• Oracle Corporation ORCL fell 7% to $67.13 after the company reported Q3 earnings results.